Marker: D14Rat75 |
| Symbol: |
D14Rat75 |
| Previously known as: |
R0097-D02; oxsts9582;
|
| RGD ID: |
39646 |
| Expected Size: |
265 (bp) |
| Position |
| Rat Assembly | Chr | Position (strand) | Source | JBrowse |
|---|
GRCr8 | 14 | 11,068,806 - 11,069,071 (+) | Marker Load Pipeline | | Rnor_6.0 | 14 | 12,414,655 - 12,414,917 | NCBI | Rnor6.0 | Rnor_5.0 | 14 | 12,357,955 - 12,358,217 | UniSTS | Rnor5.0 | RGSC_v3.4 | 14 | 12,118,227 - 12,118,490 | RGD | RGSC3.4 | RGSC_v3.4 | 14 | 12,118,228 - 12,118,490 | UniSTS | RGSC3.4 | Celera | 14 | 10,853,689 - 10,853,911 | UniSTS | | RGSC_v3.1 | 14 | 12,118,227 - 12,118,490 | RGD | | RH 2.0 Map | 4 | 946.1 | RGD | | SHRSP x BN Map | 14 | 6.9 | RGD | |
|
| Is Marker For: |
Strains:
ACI/N ;
AVN/Orl ;
BBDR/Rhw ;
BBDP/Rhw ;
BC/CpbU ;
BDIX/Han ;
BDVII/Cub ;
BN-Lx/Cub ;
BN/SsNHsd ;
BP/Cub ;
BUF/Pit ;
COP/OlaHsd ;
DA/PitN ;
FHH/Eur ;
F344/Pit ;
GH/Omr ;
GK/KyoSwe ;
DON/Melb ;
M520/N ;
IS/Kyo ;
WN/N ;
LH/Mav ;
LE/Mol ;
LEW/Pit ;
LOU/CHan ;
LN/Mav ;
MHS/Gib ;
MNR/N ;
MNRA/N ;
MNS/Gib ;
MR/Pit ;
NEDH/K ;
NP9 ;
ODU/N ;
OKA/Wsl ;
OM/Ztm ;
P5C ;
PVG/Pit ;
SD/Rij ;
SHR/OlaHsd ;
SR/Jr ;
SHRSP/Riv ;
SS/Jr ;
WAG/RijKyo ;
WF/Pit ;
WIST/Nhg ;
WKY/OlaHsd ;
WTC/Kyo
|
QTLs in Region (GRCr8)
| 1300114 | Srn2 | Serum renin concentration QTL 2 | 3.27 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 3957878 | 21572472 | Rat |
| 2293089 | Iddm31 | Insulin dependent diabetes mellitus QTL 31 | 4.7 | | blood glucose amount (VT:0000188) | age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) | 14 | 3957878 | 18558812 | Rat |
| 7411573 | Bw139 | Body weight QTL 139 | 4.7 | 0.001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 14 | 1 | 40068101 | Rat |
| 9589814 | Gluco67 | Glucose level QTL 67 | 4.54 | 0.001 | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 1 | 40068101 | Rat |
| 731183 | Pia20 | Pristane induced arthritis QTL 20 | 3.55 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 14 | 9393298 | 39411170 | Rat |
| 1331740 | Bw26 | Body weight QTL 26 | 3.028 | | body mass (VT:0001259) | body weight (CMO:0000012) | 14 | 3957878 | 31121464 | Rat |
| 71115 | Niddm15 | Non-insulin dependent diabetes mellitus QTL 15 | 4.8 | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 1 | 11334906 | Rat |
| 71117 | Niddm17 | Non-insulin dependent diabetes mellitus QTL 17 | 2.35 | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 1 | 17877928 | Rat |
| 1358296 | Ael3 | Aortic elastin QTL 3 | 3.7 | 0.00051 | aorta elastin amount (VT:0003905) | aortic elastin | 14 | 8621398 | 53621398 | Rat |
| 70195 | Mcs8 | Mammary carcinoma susceptibility QTL 8 | 4.28 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 14 | 3957878 | 24886169 | Rat |
| 634352 | Apr6 | Acute phase response QTL 6 | 3.7 | | blood interleukin-6 amount (VT:0008595) | plasma interleukin-6 level (CMO:0001927) | 14 | 1 | 41415516 | Rat |
| 70204 | Niddm20 | Non-insulin dependent diabetes mellitus QTL 20 | 5.1 | 0.000008 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 14 | 1 | 31893212 | Rat |
| 2302045 | Pia39 | Pristane induced arthritis QTL 39 | 4.9 | 0.001 | blood immunoglobulin amount (VT:0002460) | serum immunoglobulin G2a level (CMO:0002116) | 14 | 8621398 | 53621398 | Rat |